Below is an image of an Eli Lilly letter which informs doctors in the UK that Prozac is no longer authorized for use in (so-called) premenstrual dysphoric disorder (PMDD). For a larger view, please click on the image.
The wonders of mother’s breastmilk continue to amaze scientists. “Mother’s milk is a comestible marvel. It’s packed with nutrients and other benefits for babies’ health. A steady stream of research has linked breastfeeding to lower risk of infection, obesity, diabetes and respiratory disease in infants.” Unravelling the mysteries of microRNA…
Clinical Trials Controversy Spotlights Flawed System – Psychiatric News Mon, 19 Jul 2004 Recent independent analyses of the published and unpublished SSRI antidepressant pediatric data submitted by manufacturers to the FDA reveal not only that a disparity exists between published and unpublished data, but it becomes increasingly clear that the…
The Evidence base: rock of certainty or shifting sands? – BMJ Wed, 5 May 2004 Dr. John Dewhurst, has written an extraordinary article from his first-hand experience as a pharmaceutical company physician who discovered the disparity that exists between the claimed and actual evidence of drug effectiveness–and the reality-based severe,…
The pharmaceutical industry’s latest antidepression drug marketing campaign is being launched with collaboration of the National Institute of Mental Health (NIMH)—
Senate Passes Pediatric Research Equity Act Tue, 29 Jul 2003 Congress and the Bush Administration both are eager to test pharmaceutical products on children who cannot refuse to be test subjects. We at AHRP are in full agreement that medications used in children be thoroughly tested for safety, effectiveness and…
Subject: Kids are “hot ticket” in Rx drug market Date: Thu, 19 Sep 2002 17:39:52 -0400 According to MEDCO Health, which manages prescription drug plans, the records of 500,000 children under age 19 reveal that: “Kids have surpassed senior citizens as the hot ticket in the prescription drug market… Spending…
